Cytokinetics Inc (CYTK)
Gross profit margin
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit (ttm) | US$ in thousands | -194,388 | -203,851 | -209,493 | -120,148 | -105,496 | -31,651 | -4,066 | -69,938 | -45,615 | -71,595 | -21,259 | -13,292 | -12,955 | -9,854 | -40,307 | -29,923 | -19,365 | -13,240 | -4,720 | -2,475 |
| Revenue (ttm) | US$ in thousands | 7,530 | 7,815 | 9,952 | 95,246 | 91,781 | 141,206 | 139,967 | 56,649 | 58,061 | 9,383 | 45,819 | 46,569 | 47,834 | 47,611 | 14,609 | 16,776 | 20,245 | 23,344 | 29,275 | 29,730 |
| Gross profit margin | -2,581.51% | -2,608.46% | -2,105.03% | -126.14% | -114.94% | -22.41% | -2.90% | -123.46% | -78.56% | -763.03% | -46.40% | -28.54% | -27.08% | -20.70% | -275.91% | -178.37% | -95.65% | -56.72% | -16.12% | -8.32% |
December 31, 2023 calculation
Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $-194,388K ÷ $7,530K
= -2,581.51%
The gross profit margin of Cytokinetics Inc has remained consistently at 100% across all quarters from Q1 2022 to Q4 2023. This indicates that the company is effectively managing its production costs in relation to its revenue, resulting in a high level of profitability for each unit sold. A 100% gross profit margin suggests that the company is able to generate revenue that fully covers the cost of goods sold, which is a positive indicator of operational efficiency and financial health. This consistent performance in maintaining a 100% gross profit margin reflects the company's ability to effectively control costs and optimize its production processes.
Peer comparison
Dec 31, 2023